McDermott Wendy E.'s most recent trade in Lexicon Pharmaceuticals Inc was a trade of 52,317 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 52,317 | 104,633 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 52,317 | 151,650 (0%) | 0% | - | Common Stock | |
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | SVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. | 28 Feb 2025 | 30,004 | 121,646 (0%) | 0% | 0.7 | 20,103 | Common Stock |
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 27,696 | 27,697 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 27,696 | 99,333 (0%) | 0% | - | Common Stock | |
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 18,943 | 0 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 18,943 | 71,637 (0%) | 0% | - | Common Stock | |
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 649,780 | 649,780 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | SVP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 433,180 | 433,180 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | McDermott Wendy E. | VP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 27,697 | 55,393 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | McDermott Wendy E. | VP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 27,697 | 75,119 (0%) | 0% | - | Common Stock | |
| Lexicon Pharmaceuticals Inc | McDermott E. Wendy | VP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.62 per share. | 28 Feb 2024 | 22,425 | 52,694 (0%) | 0% | 2.6 | 58,754 | Common Stock |
| Lexicon Pharmaceuticals Inc | McDermott Wendy E. | VP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 18,944 | 18,943 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | McDermott Wendy E. | VP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 18,944 | 47,422 (0%) | 0% | - | Common Stock | |
| Lexicon Pharmaceuticals Inc | E. McDermott Wendy | VP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 156,950 | 156,950 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | E. Wendy McDermott | VP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 156,950 | 156,950 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | VP, Human Resources | Purchase of securities on an exchange or from another person at price $ 1.84 per share. | 04 Aug 2023 | 6,000 | 28,478 (0%) | 0% | 1.8 | 11,040 | Common Stock |
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | VP, Human Resources | Purchase of securities on an exchange or from another person at price $ 2.43 per share. | 23 Jun 2023 | 10,000 | 22,478 (0%) | 0% | 2.4 | 24,300 | Common Stock |
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | VP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 18,943 | 18,943 (0%) | 0% | - | Common Stock | |
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | VP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 18,943 | 37,887 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | VP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.17 per share. | 28 Feb 2023 | 6,465 | 12,478 (0%) | 0% | 2.2 | 14,029 | Common Stock |
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | VP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 249,280 | 249,280 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | VP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 83,090 | 83,090 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | VP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 170,500 | 170,500 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | VP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 56,830 | 56,830 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Wendy E. McDermott | VP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 85,185 | 85,185 | - | - | Stock Option (Right to Buy) |